Contemporary challenges in the Europeanpharmaceutical industry: a systematic literature review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F70883521%3A28120%2F22%3A63550498" target="_blank" >RIV/70883521:28120/22:63550498 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.emerald.com/insight/content/doi/10.1108/MBE-09-2021-0112/full/html" target="_blank" >https://www.emerald.com/insight/content/doi/10.1108/MBE-09-2021-0112/full/html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1108/MBE-09-2021-0112" target="_blank" >10.1108/MBE-09-2021-0112</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Contemporary challenges in the Europeanpharmaceutical industry: a systematic literature review

Popis výsledku v původním jazyce

Purpose – The COVID-19 pandemic creates inefficiencies in the health-care system by having devastating consequences. It has demonstrated how inefficiencies in the health system can have a significant impact on social cohesion, economic growth and public onfidence in government. The main purpose of this study is to explore the contemporary challenges faced by the pharmaceutical industry in Europe. Design/methodology/approach – This study used a systematic literature review method and adopted inclusion and exclusion criteria after constructive reviews of articles from Web of Science and Scopus databases along with the ranked journals in the Chartered Association of Business Schools to search the following key terms ‘‘challenges in the European pharmaceutical ndustry’’ during the period from2011 to 2022. The terms are set to be searched in the publications’ titles, abstracts and keywords. Findings – This study reviewed 57 papers, and the systematic review revealed the vulnerability of the European pharmaceutical industry, such as the default patent system, ineffective research and development, debate on the role of alliances, low level of expertise in the European health-care system, pharmaceutical supply chain management and other issues. Research limitations/implications – This study suggests that future research may explore the challenges of multisectoral and cross-country perspectives to get a better understanding, and for the long-term sustainability of public pharmaceutical spending, new models of enhancing research investments are needed, and Europe can still play a leading role in its tradition structure within capturing innovative ideas. Practical implications – It provides new useful insights to policymakers, global leaders and managers to devise policies to achieve a performance-oriented ulture in their institutions and firms. Social implications – The pharmaceutical sector has recognized the influence of social determinants of health. Itmoves toward sustained sound health of people to have a flourishing pharmaceutical sector. Originality/value – There is an insufficient study on the contemporary challenges of the European pharmaceutical industry. This study presents the argument that earlier studies ignored the contemporary issues facing the European pharmaceutical industry from a comprehensive and wider angle. In addition, the COVID-19 pandemic is a recent occurrence, and it causes inefficiency in the health-care sector, where the pharmaceutical industry plays a crucial role; importantly, this topic is emerging and underresearched in the existing literature. There is also a lack of systematic literature review studies in this field.

Název v anglickém jazyce

Contemporary challenges in the Europeanpharmaceutical industry: a systematic literature review

Popis výsledku anglicky

Purpose – The COVID-19 pandemic creates inefficiencies in the health-care system by having devastating consequences. It has demonstrated how inefficiencies in the health system can have a significant impact on social cohesion, economic growth and public onfidence in government. The main purpose of this study is to explore the contemporary challenges faced by the pharmaceutical industry in Europe. Design/methodology/approach – This study used a systematic literature review method and adopted inclusion and exclusion criteria after constructive reviews of articles from Web of Science and Scopus databases along with the ranked journals in the Chartered Association of Business Schools to search the following key terms ‘‘challenges in the European pharmaceutical ndustry’’ during the period from2011 to 2022. The terms are set to be searched in the publications’ titles, abstracts and keywords. Findings – This study reviewed 57 papers, and the systematic review revealed the vulnerability of the European pharmaceutical industry, such as the default patent system, ineffective research and development, debate on the role of alliances, low level of expertise in the European health-care system, pharmaceutical supply chain management and other issues. Research limitations/implications – This study suggests that future research may explore the challenges of multisectoral and cross-country perspectives to get a better understanding, and for the long-term sustainability of public pharmaceutical spending, new models of enhancing research investments are needed, and Europe can still play a leading role in its tradition structure within capturing innovative ideas. Practical implications – It provides new useful insights to policymakers, global leaders and managers to devise policies to achieve a performance-oriented ulture in their institutions and firms. Social implications – The pharmaceutical sector has recognized the influence of social determinants of health. Itmoves toward sustained sound health of people to have a flourishing pharmaceutical sector. Originality/value – There is an insufficient study on the contemporary challenges of the European pharmaceutical industry. This study presents the argument that earlier studies ignored the contemporary issues facing the European pharmaceutical industry from a comprehensive and wider angle. In addition, the COVID-19 pandemic is a recent occurrence, and it causes inefficiency in the health-care sector, where the pharmaceutical industry plays a crucial role; importantly, this topic is emerging and underresearched in the existing literature. There is also a lack of systematic literature review studies in this field.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

50204 - Business and management

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Measuring Business Excellence

ISSN

1368-3047

e-ISSN

—

Svazek periodika

neuveden

Číslo periodika v rámci svazku

neuvedeno

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

14

Strana od-do

nestrankovano

Kód UT WoS článku

000878726700001

EID výsledku v databázi Scopus

2-s2.0-85141414541